不同剂量丁苯酞治疗脑梗死的效果对比

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of different doses of Butylphthalide in the treatment of cerebral infarction.Methods A total of 80 patients with cerebral infarction admitted to our hospital from December 2015 to December 2017 were selected as the research objects.According to the random sampling method,they were divided into control group and observation group,with 40 cases in each group.All patients were treated with Butylphthalide.The dose of control group was 100 mg/time,and that of observation group was 200 mg/time.All patients were treated for one month.The short-term curative effect of two groups of cerebral infarction patients was compared.Results The neurological deficit scores of the patients with cerebral infarction in the observation group were lower than those in the control group at 2 weeks and 1 month after treatment,and the differences were statistically significant(P<0.05).The scores of daily living ability index in the observation group were higher than those in the control group at 2 weeks and 1 month after treatment,and the differences were statistically significant(P<0.05).The total effective rate of the observation group was higher than that of the control group for one month,and the difference was statistically significant(P<0.05).Conclusion High dose of Butylphthalide in the treatment of cerebral infarction in the short term effect is remarkable,can significantly improve the neurological deficits in patients with cerebral infarction,and improve the daily living ability of patients,improve the quality of life of patients,the application effect is satisfactory.

Key words： Different doses Butylphthalide Cerebral infarction Short-term efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LYU Jiang-hua

Cite this article:

LYU Jiang-hua. Effect comparison of different doses of Butylphthalide in the treatment of cerebral infarction[J]. 中国当代医药, 2019, 26(16): 68-70.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I16/68

[1]	翁逸菲.不同剂量丁苯酞对急性脑梗死患者的疗效评价[J].中国慢性病预防与控制，2018，26（1）：71-73.
[2]	杜双双.不同剂量丁苯酞治疗脑梗塞的近期疗效及作用机制研究[J].医药论坛杂志，2017，38（1）：162-164.
[3]	段金平.不同剂量丁苯酞及安慰剂治疗脑梗死的神经功能作用及安全性[J].中国实用神经疾病杂志，2017，20（1）：121-122.
[4]	李建波，杨玉峰.不同剂量丁苯酞与安慰剂治疗脑梗死的近远期疗效比较[J].中国实用神经疾病杂志，2016，19（22）：46-48.
[5]	俞小梅，王喜丰，张静.丁苯酞注射液及丁苯酞胶囊治疗急性脑梗死患者的临床疗效对比[J].实用医学杂志，2016，32（17）：2921-2924.
[6]	宋轶群，刘梅，于广.丁苯酞对急性脑梗死患者认知功能和血清学指标的影响及二者相关性分析[J].中国药房，2017，28（2）：243-246.
[7]	孙志宏.丁苯酞治疗急性脑梗死的临床疗效及其血管内皮功能的影响[J].医学研究杂志，2016，45（6）：158-160.
[8]	张雨时.阿加曲班联合丁苯酞治疗急性脑梗死的临床疗效探讨[J].中国现代药物应用，2018，12（22）：85-87.
[9]	闵阳.阿司匹林联合丁苯酞软胶囊治疗急性脑梗死的临床疗效评价[J].中国医药指南，2018，16（30）：52-53.
[10]	卞科宇，金华锋，李骏.联用阿替普酶和丁苯酞治疗急性脑梗死对患者血清MMP-9、VEGF水平的影响[J].当代医药论丛，2018，16（11）：201-202.
[11]	李亚范.依达拉奉与丁苯酞联合治疗急性脑梗死的疗效[J].中国社区医师，2018，34（13）：49-50.
[12]	曾宏亮，曾祥俊.阿替普酶联合丁苯酞注射液治疗急性脑梗死的效果[J].中国当代医药，2018，25（23）：148-150.
[13]	丁香.丁苯酞软胶囊联合依达拉奉对急性脑梗死患者神经功能的影响[J].中国现代医生，2019，57（1）：51-53.
[14]	程晓利.氯吡格雷联合丁苯酞软胶囊治疗急性脑梗死患者的效果[J].河南医学研究，2018，27（13）：2387-2388.
[15]	李恒楠.丹红注射液联合丁苯酞治疗脑梗死急性期患者的临床观察[J].中西医结合心血管病杂志（电子版），2018，6（18）：89-90.